Kite Pharma, Inc. - FORM 10-Q - XML - IDEA: XBRL DOCUMENT - August 10, 2015

Attached files

file filename
EX-31.2 - EX-31.2 - Kite Pharma, Inc.kite-ex312_7.htm
EX-31.1 - EX-31.1 - Kite Pharma, Inc.kite-ex311_6.htm
EX-32.1 - EX-32.1 - Kite Pharma, Inc.kite-ex321_10.htm
EX-32.2 - EX-32.2 - Kite Pharma, Inc.kite-ex322_12.htm
EX-10.2 - EX-10.2 - Kite Pharma, Inc.kite-ex102_193.htm
EX-10.3 - EX-10.3 - Kite Pharma, Inc.kite-ex103_166.htm
EX-10.1 - EX-10.1 - Kite Pharma, Inc.kite-ex101_196.htm
10-Q - 10-Q - Kite Pharma, Inc.kite-10q_20150630.htm
v3.2.0.727
Label Element Value
Accumulated Other Comprehensive Income [Member]  
Stockholders Equity us-gaap_StockholdersEquity $ (297)
Additional Paid In Capital [Member]  
Stockholders Equity us-gaap_StockholdersEquity $ 420,848
Common Stock [Member]  
Shares Outstanding us-gaap_SharesOutstanding 41,855,304
Stockholders Equity us-gaap_StockholdersEquity $ 42
Retained Earnings [Member]  
Stockholders Equity us-gaap_StockholdersEquity $ (58,004)

Kite Pharma, Inc. Reports